Soligenix Inc. receives FDA Orphan Drug Designation for dusquetide in Behçet’s Disease, showcasing positive Phase 2a results. On the other hand, Creative Biolabs offers specialized antibody QC services and a scholarship program for students in biology and related fields, emphasizing innovation in antibody development.
